U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07694570) titled 'Feasibility Study: Continuous ECG and Blood Pressure Monitoring With the M2VS Sensor System' on June 25.
Brief Summary: In this study, the investigators want to find out whether a new wearable sensor system, called the M2VS system, can reliably measure heart activity, blood pressure, and other vital signs over 24 hours during normal daily life.
The investigators also want to compare the M2VS system with the standard devices currently used for long-term heart and blood pressure monitoring, such as a Holter ECG and an ambulatory blood pressure monitor (ABPM). This will provide an estimation of the accuracy of the M2VS system's ECG an...